Pharma growth: AstraZeneca profit surges 77% to $2.53 bn in Q3; US expansion and cancer drugs power strong results
AstraZeneca reported a significant 77% surge in quarterly net profit, reaching $2.53 billion, driven by strong US growth and robust sales of its cancer drugs. ...
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns ...
